You just read:

New Halaven® (eribulin) and Lenvima® (lenvatinib) Data to be Presented at ESMO Demonstrate Continued Commitment to Eisai Oncology Portfolio

News provided by

Eisai Inc.

29 Sep, 2016, 08:30 ET